Eugene Goldenberg is a Director in the Firm’s Corporate M&A Advisory practice. Mr. Goldenberg joined Cain Brothers in 2012 with over 6 years’ healthcare services equity research experience covering many of the same sector verticals where he now utilizes his advisory and deal execution capabilities. Mr. Goldenberg’s recent notable transactions include the sale of St. Croix Hospice to the Vistria Group, the sale of TMG Health (a subsidiary of HCSC) to Cognizant Technology Solutions, the sale of New Century Hospice to Curo Health Services, a private placement by Coliseum Capital on behalf of BioScrip, the sale of Salveo Specialty Pharmacy to Catamaran, LASIK Vision Institute’s acquisition of TLC Laser Eye Centers, the sale of LCA-Vision to PhotoMedex, and the sale of BioScrip’s Home Health Services Business to LHC Group.
Prior to joining Cain Brothers, Mr. Goldenberg was a Senior Equity Research Analyst at BB&T Capital Markets, where he focused on various healthcare services verticals, including Post-Acute Care (Home Health, Hospice, Skilled Nursing Facilities, and Long-Term Acute Care Hospitals), as well as Pharmacy Benefit Managers, Specialty Supplies Distribution, Community-Based Services, Specialty Pharmacy, Home Infusion, Healthcare IT, and Wellness / Disease Management.
Mr. Goldenberg’s prior experience also includes working within Morgan Stanley’s Controller Financial Reporting group.
Mr. Goldenberg graduated with high honors from Rutgers University with a BS in Finance and a minor in Art History.
Todd Rudsenske co-leads Cain Brothers’ Behavioral Health Advisory practice and leads the Firm’s Financial Sponsors and Corporate Private Placement Advisory practices. Mr. Rudsenske joined Cain Brothers in 2003 and has over 20 years’ experience advising private and public companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Rudsenske’s notable transactions include the sale of Foundations Recovery Network to N Pritzker Capital Management, the sale of Remuda Ranch to The Meadows, the sale of US Community Behavioral to Bregal Partners, the sale of Camelot to Sequel, and CRC Health Group’s acquisition of Habit Opco. He is a frequent speaker on the subject of private equity investment in the healthcare sector and has also authored or coauthored several articles on the business of healthcare, one of which was published by Health Affairs. Prior to joining Cain Brothers, Mr. Rudsenske was at Merrill Lynch in that firm’s Palo Alto office specializing in equity private placements. Prior to that, Mr. Rudsenske was in Merrill Lynch’s New York office where he was focused on healthcare mergers & acquisitions for not-for-profit organizations. Prior to Merrill Lynch, Mr. Rudsenske was in Ernst & Young’s Corporate Finance Group, focusing on executing strategic transactions for that firm’s healthcare clients. He began his career on the audit staff of Ernst & Young in Dallas. Mr. Rudsenske earned a BBA in Finance and Accounting from Texas A&M University and earned his MBA from the Columbia Business School. Mr. Rudsenske is also a Certified Public Accountant.
Eugene Goldenberg is a Vice President in the Firm’s Corporate M&A Advisory practice. Mr. Goldenberg joined Cain Brothers in 2012 with over 6 years’ healthcare services equity research experience covering many of the same sector verticals where he now utilizes his advisory and deal execution capabilities. Mr. Goldenberg’s recent notable transactions include a private placement by Coliseum Capital on behalf of BioScrip, the sale of Salveo Specialty Pharmacy to Catamaran, LASIK Vision Institute’s acquisition of TLC Laser Eye Centers, the sale of LCA-Vision to PhotoMedex, and the sale of BioScrip’s Home Health Services Business to LHC Group. Prior to joining Cain Brothers, Mr. Goldenberg was a Senior Equity Research Analyst at BB&T Capital Markets, where he focused on various healthcare services verticals, including Post-Acute Care (Home Health, Hospice, Skilled Nursing Facilities, and Long-Term Acute Care Hospitals), as well as Pharmacy Benefit Managers, Specialty Supplies Distribution, Community-Based Services, Specialty Pharmacy, Home Infusion, Healthcare IT, and Wellness / Disease Management. Mr. Goldenberg’s prior experience also includes working within Morgan Stanley’s Controller Financial Reporting group.
Todd Rudsenske co-leads Cain Brothers’ Behavioral Health Advisory practice and leads the Firm’s Financial Sponsors and Corporate Private Placement Advisory practices. Mr. Rudsenske joined Cain Brothers in 2003 and has over 20 years’ experience advising private and public companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Rudsenske’s notable transactions include the sale of Foundations Recovery Network to N Pritzker Capital Management, the sale of Remuda Ranch to The Meadows, the sale of US Community Behavioral to Bregal Partners, the sale of Camelot to Sequel, and CRC Health Group’s acquisition of Habit Opco. He is a frequent speaker on the subject of private equity investment in the healthcare sector and has also authored or co-authored several articles on the business of healthcare, one of which was published by Health Affairs.
Prior to joining Cain Brothers, Mr. Rudsenske was at Merrill Lynch in that firm’s Palo Alto office specializing in equity private placements. Prior to that, Mr. Rudsenske was in Merrill Lynch’s New York office where he was focused on healthcare mergers & acquisitions for not-for-profit organizations. Prior to Merrill Lynch, Mr. Rudsenske was in Ernst & Young’s Corporate Finance Group, focusing on executing strategic transactions for that firm’s healthcare clients. He began his career on the audit staff of Ernst & Young in Dallas.
Mr. Rudsenske earned a BBA in Finance and Accounting from Texas A&M University and earned his MBA from the Columbia Business School. Mr. Rudsenske is also a Certified Public Accountant.
Wyatt Ritchie joined Cain Brothers in 2010 as a Managing Director in the San Francisco office. Prior to joining the firm, Wyatt had been a Managing Director at Jefferies & Company responsible for the firm’s health care services practice. Prior to joining Jefferies, Wyatt had been at CIBC Oppenheimer for eight years where he was responsible for the firm’s West Coast health care services investment banking practice and at Bank of America where he was responsible for Bank of America’s health care leverage finance business. Over the past 19 years, Wyatt has been involved in mergers and acquisitions, strategic advisory, public and private debt and equity financings. Wyatt earned a BA in Economics from St. Olaf College and an MBA in Finance from the University of Chicago.
Director, Cain Brothers
Managing Director, Cain Brothers & Company, LLC
Managing Director, Cain Brothers